|
CN112168835A
|
|
Application of murysicin in preparation of cholagogue drugs
|
|
CN112251496A
|
|
MicroRNA biosensor for triggering 3-D double-leg DNA walker through exponential amplification reaction
|
|
CN112002427A
|
|
Construction method of model for predicting risk of decompensated liver cirrhosis combined infection
|
|
CN112185547A
|
|
Method for detecting adverse reaction signals of drug sex difference
|
|
CN112117006A
|
|
Type 2 diabetes kidney disease risk assessment system based on ensemble learning
|
|
CN112121061A
|
|
Construction and application of multifunctional hollow cerium nano-particles and hollow cerium nano-composite drug-loading system
|
|
CN112029839A
|
|
Biosensor for rapidly detecting multiple drug-resistant acinetobacter baumannii by combining multiple PCR and CRISPR-Cas
|
|
CN112062863A
|
|
Activated blood coagulation factor XIIIA and batroxobin BTX fusion protein and construction method and application thereof
|
|
CN111904967A
|
|
Application of 2-APB in preparation of medicine for treating non-alcoholic steatohepatitis
|
|
CN112125909A
|
|
Preparation process of vildagliptin impurity
|
|
CN112028978A
|
|
Novel coronavirus specific CD8+T cell epitope peptide and application thereof
|
|
CN111995618A
|
|
Preparation method of neratinib impurity G
|
|
CN111943933A
|
|
Preparation method of neratinib impurity D
|
|
CN112033720A
|
|
Crime scene sampling device and evidence observation device
|
|
CN111773224A
|
|
Application of compound in cancer treatment medicine
|
|
CN112198128A
|
|
Multi-enzyme joint detection device for blood amylase and alkaline phosphatase and detection method thereof
|
|
CN111909263A
|
|
New coronavirus RBD specific monoclonal antibody and application
|
|
CN111925443A
|
|
New coronavirus RBD specific monoclonal antibody and application
|
|
CN111925442A
|
|
New coronavirus RBD specific monoclonal antibody and application
|
|
CN111925440A
|
|
New coronavirus RBD specific monoclonal antibody and application
|
